Increased mortality in COVID-19 patients with fungal co- and secondary infections admitted to intensive care or high dependency units in NHS hospitals in England

Affiliations

• ¹ UK Health Security Agency, Reference Services Division, UK National Mycology Reference Laboratory, Science Quarter, Southmead Hospital, Bristol BS10 5NB, United Kingdom; Medical Research Council Centre for Medical Mycology (MRC CMM), University of Exeter, Exeter EX4 4QD, United Kingdom. Electronic address: Andy.Borman@nbt.nhs.uk.
• ² HCAI, Fungal, AMR, AMU and Sepsis Division, UK Health Security Agency. Colindale, London NW9 5HT, United Kingdom.
• ³ Immunisation and Vaccine Preventable Diseases, UK Health Security Agency. Colindale. London NW9 5HT, United Kingdom.
• ⁴ Reference Services Division, Bacterial Reference Department, National Infections Service, UK Health Security Agency, Colindale. London NW9 5HT, United Kingdom.
• ⁵ UK Health Security Agency, Reference Services Division, UK National Mycology Reference Laboratory, Science Quarter, Southmead Hospital, Bristol BS10 5NB, United Kingdom; Medical Research Council Centre for Medical Mycology (MRC CMM), University of Exeter, Exeter EX4 4QD, United Kingdom.